ECSP10010246A - Inhibidores de beta-lactamasa - Google Patents
Inhibidores de beta-lactamasaInfo
- Publication number
- ECSP10010246A ECSP10010246A EC2010010246A ECSP10010246A ECSP10010246A EC SP10010246 A ECSP10010246 A EC SP10010246A EC 2010010246 A EC2010010246 A EC 2010010246A EC SP10010246 A ECSP10010246 A EC SP10010246A EC SP10010246 A ECSP10010246 A EC SP10010246A
- Authority
- EC
- Ecuador
- Prior art keywords
- beta
- inhibitors
- lactamasa
- alpha
- amino
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title 1
- 239000003781 beta lactamase inhibitor Substances 0.000 abstract 1
- 229940126813 beta-lactamase inhibitor Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
En la presente se dan a conocer ácidos alfa-amino-borónicos y sus derivados, los cuales actúan como inhibidores de beta-lactamasas. También, en la presente se dan a conocer composiciones farmacéuticas que comprenden ácidos alfa-amino-borónicos, y métodos de uso de las mismas.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US279707P | 2007-11-13 | 2007-11-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP10010246A true ECSP10010246A (es) | 2010-07-30 |
Family
ID=40344560
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2010010246A ECSP10010246A (es) | 2007-11-13 | 2010-06-11 | Inhibidores de beta-lactamasa |
Country Status (21)
Country | Link |
---|---|
US (2) | US20100286092A1 (es) |
EP (2) | EP2220096A1 (es) |
JP (2) | JP2011503181A (es) |
KR (2) | KR20100109901A (es) |
CN (2) | CN101861324A (es) |
AR (2) | AR069310A1 (es) |
AU (2) | AU2008321444A1 (es) |
BR (2) | BRPI0820532A2 (es) |
CA (2) | CA2705389A1 (es) |
CO (1) | CO6331427A2 (es) |
CR (1) | CR11372A (es) |
EA (2) | EA201000775A1 (es) |
EC (1) | ECSP10010246A (es) |
GT (1) | GT201000143A (es) |
IL (1) | IL205205A0 (es) |
MA (1) | MA31874B1 (es) |
MX (2) | MX2010005252A (es) |
TN (1) | TN2010000203A1 (es) |
TW (2) | TW200930707A (es) |
WO (2) | WO2009064414A1 (es) |
ZA (1) | ZA201002467B (es) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100120715A1 (en) * | 2007-11-13 | 2010-05-13 | Burns Christopher J | Beta-lactamase inhibitors |
AR076667A1 (es) * | 2009-05-12 | 2011-06-29 | Novartis Int Pharm Ltd | Inhibidores de beta-lactamasa |
ES2691468T3 (es) | 2010-08-10 | 2018-11-27 | Rempex Pharmaceuticals, Inc. | Derivados de éster del ácido borónico cíclicos y usos terapéuticos de los mismos |
US9012491B2 (en) | 2011-08-31 | 2015-04-21 | Rempex Pharmaceuticals, Inc. | Heterocyclic boronic acid ester derivatives and therapeutic uses thereof |
SG10201605152SA (en) * | 2011-12-22 | 2016-08-30 | Ares Trading Sa | Alpha-amino boronic acid derivatives, selective immunoproteasome inhibitors |
MX2014008278A (es) * | 2012-01-06 | 2014-11-10 | Univ South Florida | Composiciones, metodos de uso y metodos de tratamiento. |
TW201343645A (zh) * | 2012-03-30 | 2013-11-01 | Cubist Pharm Inc | 1,3,4-□二唑及1,3,4-噻二唑β-內醯胺酶抑制劑 |
US9156858B2 (en) | 2012-05-23 | 2015-10-13 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
US10561675B2 (en) | 2012-06-06 | 2020-02-18 | Rempex Pharmaceuticals, Inc. | Cyclic boronic acid ester derivatives and therapeutic uses thereof |
RU2654692C2 (ru) * | 2012-12-07 | 2018-05-22 | Венаторкс Фармасьютикалс, Инк. | Ингибиторы бета-лактамаз |
JP2016509594A (ja) * | 2013-01-04 | 2016-03-31 | レンペックス・ファーマシューティカルズ・インコーポレイテッド | ボロン酸誘導体及びその治療的使用 |
JP6324409B2 (ja) | 2013-01-04 | 2018-05-16 | レンペックス・ファーマシューティカルズ・インコーポレイテッド | ボロン酸誘導体及びその治療的使用 |
US9101638B2 (en) | 2013-01-04 | 2015-08-11 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
US9241947B2 (en) | 2013-01-04 | 2016-01-26 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
WO2014110442A1 (en) | 2013-01-10 | 2014-07-17 | VenatoRx Pharmaceuticals, Inc. | Beta-lactamase inhibitors |
EP2970340B1 (en) * | 2013-03-14 | 2020-02-12 | Venatorx Pharmaceuticals, Inc. | Beta-lactamase inhibitors |
DK3140310T3 (da) | 2014-05-05 | 2019-10-21 | Rempex Pharmaceuticals Inc | Syntese af boronatsalte og brug deraf |
EP3139930A4 (en) * | 2014-05-05 | 2018-01-17 | Rempex Pharmaceuticals, Inc. | Salts and polymorphs of cyclic boronic acid ester derivatives and therapeutic uses thereof |
EP3145936B1 (en) * | 2014-05-19 | 2020-09-30 | Qpex Biopharma, Inc. | Boronic acid derivatives and therapeutic uses thereof |
RU2686740C2 (ru) * | 2014-06-11 | 2019-04-30 | Венаторкс Фармасьютикалс, Инк. | Ингибиторы бета-лактамазы |
US9511142B2 (en) | 2014-06-11 | 2016-12-06 | VenatoRx Pharmaceuticals, Inc. | Beta-lactamase inhibitors |
EP3164406A4 (en) * | 2014-07-01 | 2018-04-04 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
ES2811273T3 (es) * | 2014-10-01 | 2021-03-11 | Merck Patent Gmbh | Derivados del ácido borónico |
EP3201207B1 (en) * | 2014-10-01 | 2021-02-24 | Merck Patent GmbH | Boronic acid derivatives |
US10253049B2 (en) * | 2014-10-01 | 2019-04-09 | Merck Patent Gmbh | Boronic acid derivatives |
WO2016081297A1 (en) | 2014-11-18 | 2016-05-26 | Rempex Pharmaceuticals, Inc. | Cyclic boronic acid ester derivatives and therapeutic uses thereof |
CN107207537B (zh) | 2014-12-19 | 2019-05-31 | 莱姆派克斯制药公司 | 用于生产硼酸衍生物的设备和连续流方法 |
WO2016149393A1 (en) | 2015-03-17 | 2016-09-22 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
CN108472284A (zh) | 2015-09-11 | 2018-08-31 | 维纳拓尔斯制药公司 | β-内酰胺酶抑制剂 |
WO2017100537A1 (en) | 2015-12-10 | 2017-06-15 | VenatoRx Pharmaceuticals, Inc. | Beta-lactamase inhibitors |
CN109563033B (zh) | 2016-06-21 | 2023-04-04 | 奥瑞恩眼科有限责任公司 | 脂族脯氨酰胺衍生物 |
ES2894251T3 (es) | 2016-06-30 | 2022-02-14 | Qpex Biopharma Inc | Derivados de ácido borónico y usos terapéuticos de los mismos |
WO2018027062A1 (en) | 2016-08-04 | 2018-02-08 | VenatoRx Pharmaceuticals, Inc. | Boron-containing compounds |
EP3592362A4 (en) | 2017-03-06 | 2020-09-02 | Venatorx Pharmaceuticals, Inc. | SOLID FORMS AND COMBINATION COMPOSITIONS WITH A BETA LACTAMASE INHIBITOR AND USES THEREOF |
US11267826B2 (en) | 2017-05-26 | 2022-03-08 | VenatoRx Pharmaceuticals, Inc. | Penicillin-binding protein inhibitors |
CN110959008A (zh) * | 2017-05-26 | 2020-04-03 | 维纳拓尔斯制药公司 | 青霉素结合蛋白抑制剂 |
WO2019009369A1 (ja) * | 2017-07-06 | 2019-01-10 | 大日本住友製薬株式会社 | イミン誘導体 |
TW201906616A (zh) * | 2017-07-06 | 2019-02-16 | 日商大日本住友製藥股份有限公司 | 醯胺衍生物 |
JP7377545B2 (ja) | 2017-10-11 | 2023-11-10 | キューペックス バイオファーマ, インコーポレイテッド | ボロン酸誘導体およびその合成 |
CN112424209A (zh) | 2018-04-20 | 2021-02-26 | Qpex生物制药有限公司 | 硼酸衍生物及其治疗用途 |
WO2020112542A1 (en) * | 2018-11-29 | 2020-06-04 | VenatoRx Pharmaceuticals, Inc. | Combination compositions comprising a beta-lactamase inhibitor and uses thereof |
CN110156820B (zh) * | 2019-04-25 | 2021-06-25 | 四川大学 | 一类巯基酰胺硼酸类衍生物及其作为mbl和/或sbl抑制剂的用途 |
WO2020257306A1 (en) | 2019-06-19 | 2020-12-24 | Qpex Biopharma, Inc. | Boronic acid derivatives and therapeutic uses thereof |
CN113135944A (zh) * | 2020-01-19 | 2021-07-20 | 首药控股(北京)有限公司 | 硼酸衍生物 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7112572B2 (en) * | 2002-09-09 | 2006-09-26 | Trigen Limited | Multivalent metal salts of boronic acids |
US20060084592A1 (en) * | 2002-09-09 | 2006-04-20 | Trigen Limited | Peptide boronic acid inhibitors |
US7271186B1 (en) * | 2002-12-09 | 2007-09-18 | Northwestern University | Nanomolar β-lactamase inhibitors |
US7183267B2 (en) * | 2003-06-10 | 2007-02-27 | The Johns Hopkins University | β-lactamase inhibitors and methods of use thereof |
US20100120715A1 (en) * | 2007-11-13 | 2010-05-13 | Burns Christopher J | Beta-lactamase inhibitors |
AR076667A1 (es) * | 2009-05-12 | 2011-06-29 | Novartis Int Pharm Ltd | Inhibidores de beta-lactamasa |
-
2008
- 2008-11-13 CN CN200880112051A patent/CN101861324A/zh active Pending
- 2008-11-13 WO PCT/US2008/012706 patent/WO2009064414A1/en active Application Filing
- 2008-11-13 EP EP08848632A patent/EP2220096A1/en not_active Withdrawn
- 2008-11-13 CA CA2705389A patent/CA2705389A1/en not_active Abandoned
- 2008-11-13 MX MX2010005252A patent/MX2010005252A/es not_active Application Discontinuation
- 2008-11-13 AU AU2008321444A patent/AU2008321444A1/en not_active Withdrawn
- 2008-11-13 US US12/742,526 patent/US20100286092A1/en not_active Abandoned
- 2008-11-13 MX MX2010005250A patent/MX2010005250A/es not_active Application Discontinuation
- 2008-11-13 KR KR1020107012951A patent/KR20100109901A/ko not_active Application Discontinuation
- 2008-11-13 BR BRPI0820532-9A patent/BRPI0820532A2/pt not_active Application Discontinuation
- 2008-11-13 JP JP2010534032A patent/JP2011503181A/ja not_active Withdrawn
- 2008-11-13 KR KR1020107012952A patent/KR20100113485A/ko not_active Application Discontinuation
- 2008-11-13 TW TW097143879A patent/TW200930707A/zh unknown
- 2008-11-13 CA CA2705393A patent/CA2705393A1/en not_active Withdrawn
- 2008-11-13 WO PCT/US2008/012705 patent/WO2009064413A1/en active Application Filing
- 2008-11-13 JP JP2010534031A patent/JP2011504468A/ja active Pending
- 2008-11-13 AR ARP080104957A patent/AR069310A1/es unknown
- 2008-11-13 EA EA201000775A patent/EA201000775A1/ru unknown
- 2008-11-13 US US12/742,548 patent/US20100317621A1/en not_active Abandoned
- 2008-11-13 EP EP08848689A patent/EP2220097A1/en not_active Withdrawn
- 2008-11-13 AR ARP080104956A patent/AR069463A1/es unknown
- 2008-11-13 CN CN2008801159624A patent/CN101983203A/zh active Pending
- 2008-11-13 BR BRPI0820531-0A patent/BRPI0820531A2/pt not_active Application Discontinuation
- 2008-11-13 EA EA201000774A patent/EA201000774A1/ru unknown
- 2008-11-13 AU AU2008321443A patent/AU2008321443A1/en not_active Abandoned
- 2008-11-13 TW TW097143877A patent/TW200936143A/zh unknown
-
2010
- 2010-04-08 ZA ZA2010/02467A patent/ZA201002467B/en unknown
- 2010-04-15 CR CR11372A patent/CR11372A/es not_active Application Discontinuation
- 2010-04-19 IL IL205205A patent/IL205205A0/en unknown
- 2010-05-07 TN TN2010000203A patent/TN2010000203A1/fr unknown
- 2010-05-12 CO CO10056779A patent/CO6331427A2/es not_active Application Discontinuation
- 2010-05-13 GT GT201000143A patent/GT201000143A/es unknown
- 2010-05-31 MA MA32883A patent/MA31874B1/fr unknown
- 2010-06-11 EC EC2010010246A patent/ECSP10010246A/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP10010246A (es) | Inhibidores de beta-lactamasa | |
UY32626A (es) | Inhibidores de beta-lactamasa | |
GT201000023A (es) | Nuevos derivados de 6-trialzolopiridacina-sulfanil benzotiazol y bencimidazol, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nueva utilizacion principalmente como inhibidores de met. | |
HN2006035237A (es) | Derivados de triazolopiridina en calidad de inhibidores de lipasas y fosfolipasas | |
CR11427A (es) | 2-fluoro-2 - desoxitetrahidrouridinas como inhibidores de citidina desaminasa | |
CR20110216A (es) | Derivados de ácido 1-amino-2-ciclobutiletilborónico | |
CO6321282A2 (es) | Derivados de piperidinilindol como inhibidores de aldosterona sintasa | |
HN2007000267A (es) | Compuestos de 4-metil piridopirimidinoma | |
UY31481A1 (es) | Nuevos derivados de pirimidina, procesos de preparacion, composiciones farmacéuticas conteniéndolos y aplicaciones | |
UY29853A1 (es) | Derivados de diacilindazol como inhibidores de lipasas y fosfolipasas- | |
CR11373A (es) | COMPUESTOS DE TIENOPIRIMIDINA Y PIRAZOLOPIRIMIDINA Y SU USO COMO INHIBIDORES DE mTOR CINASA Y PI3 CINASA | |
CR20110135A (es) | INHIBIDORES DE cMET | |
UY30498A1 (es) | Nueva clase de compuestos de benzimidazolilo, sus sales, composiciones farmacéuticas conteniéndolos y aplicaciones | |
UY32863A (es) | COMPUESTOS DE HEXAHIDROOXAZINOPTERINA PARA USO COMO INHIBIDORES DE mTOR | |
CR10148A (es) | Derivados de las benzamidas y heteroarenos | |
CR20110562A (es) | Compuestos y métodos para la modulación de las quinasas e indicaciones de los mismos | |
UY30796A1 (es) | 3-h-pirazolopiridinas y sales de éstas, composiciones farmacéuticas que las comprenden, métodos para prepararlas, y sus usos | |
ECSP109856A (es) | Derivados de oxadiazol y su uso como potenciadores de los receptores metabotrópicos de glutamato - 842 | |
DOP2011000076A (es) | Derivados de heteroaril amidas y su uso como activadores de glucoquinasa | |
DOP2014000036A (es) | Compuestos de piridazinona y su uso como inhibidores daao | |
PA8667201A1 (es) | Nuevos compuestos farmaceuticos | |
UY31001A1 (es) | Derivados de imidazolidinacarboxamida como inhibidores de lipasas y fosfolipasas | |
DOP2006000226A (es) | Derivados de carbamoilbenzotriazol como inhibidores de lipasas fosfolipasas | |
GT200900192A (es) | Derivados de imidazol como inhibidores de proteina de uso de cinesina (eg-5).- | |
DOP2009000215A (es) | Administracion semanal de inhibidores de peptidasa de pipeptidilo |